General Information of Drug Therapeutic Target (DTT) (ID: TTM5Q4V)

DTT Name Organic cation transporter 1
Synonyms Solute carrier family 22 member 1; hOCT1; SLC22A1
Gene Name SLC22A1
BioChemical Class
Single Protein
UniProt ID
S22A1_HUMAN
TTD ID
TE0106
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MPTVDDILEQVGESGWFQKQAFLILCLLSAAFAPICVGIVFLGFTPDHHCQSPGVAELSQ
RCGWSPAEELNYTVPGLGPAGEAFLGQCRRYEVDWNQSALSCVDPLASLATNRSHLPLGP
CQDGWVYDTPGSSIVTEFNLVCADSWKLDLFQSCLNAGFLFGSLGVGYFADRFGRKLCLL
GTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGYTLITEFVGSGSRRTVAIMY
QMAFTVGLVALTGLAYALPHWRWLQLAVSLPTFLFLLYYWCVPESPRWLLSQKRNTEAIK
IMDHIAQKNGKLPPADLKMLSLEEDVTEKLSPSFADLFRTPRLRKRTFILMYLWFTDSVL
YQGLILHMGATSGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNLLAGAACLVM
IFISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSSLCDIGGIIT
PFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVALPETMKDAENLGRKAKPKEN
TIYLKVQTSEPSGT
Function
Translocates a broad array of organic cations with various structures and molecular weights including the model compounds 1-methyl-4-phenylpyridinium (MPP), tetraethylammonium (TEA), N-1-methylnicotinamide (NMN), 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP), the endogenous compounds choline, guanidine, histamine, epinephrine, adrenaline, noradrenaline and dopamine, and the drugs quinine, and metformin.

The Drug Transporter (DTP) Role of This DTT

DTT DTP Name Organic cation transporter 1 (SLC22A1) DTP Info
Gene Name SLC22A1
65 Approved Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acebutolol DM0TI4U Hypertension BA00-BA04 Approved [1]
Acetylcholine DMDF79Z Cataract 9B10 Approved [2]
Aciclovir DMYLOVR Genital herpes 1A94 Approved [3]
Amiloride DMRTSGP Congestive heart failure BD10 Approved [4]
Atenolol DMNKG1Z Angina pectoris BA40 Approved [4]
Atropine DMEN6X7 Organophosphate poisoning NE6Z Approved [4]
Auranofin DMWE2N4 Inflammatory arthritis FA2Z Approved [5]
Buformin DMX82DO N. A. N. A. Approved [6]
Cimetidine DMH61ZB Acid-reflux disorder DA22 Approved [4]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [7]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [8]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [6]
Clidinium DMUMQZ0 Abdominal stomach pain DD91.4 Approved [4]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [9]
Codeine DMJX6ZG Allergic rhinitis CA08.0 Approved [10]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [6]
Debrisoquin DMC50ME Hypertension BA00-BA04 Approved [11]
Desipramine DMT2FDC Attention deficit hyperactivity disorder 6A05.Z Approved [1]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [12]
Disopyramide DM5SYZP Long QT syndrome BC65.0 Approved [4]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [8]
Epinephrine DM3KJBC Acute asthma CA23 Approved [6]
Fenoterol DMIP3ZV Asthma CA23 Approved [4]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [13]
Formoterol DMSOURV Allergic asthma CA23.0 Approved [4]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [3]
Glycopyrrolate DM2M3ZA Anaesthesia 9A78.6 Approved [4]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [14]
Indacaterol DMQJHR7 Chronic obstructive pulmonary disease CA22 Approved [4]
Ipratropium DMFQ320 Obstructive lung disease CA22.Z Approved [4]
Lamivudine DMI347A Chronic HBV infection 1E51.0Z Approved [15]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [16]
Metformin DM89QE1 Colorectal carcinoma Approved [17]
Metoclopramide DMFA5MY Nausea MD90 Approved [4]
Naratriptan DMO50U2 Headache 8A80-8A84 Approved [18]
Nizatidine DMGFV3Z Acid-reflux disorder DA22 Approved [4]
Norepinephrine DMOUC09 Alopecia ED70 Approved [8]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [19]
Oxyphenonium DMMQHOZ Visceral spasms MD81.4 Approved [4]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [20]
Perphenazine DMA4MRX Schizophrenia 6A20 Approved [4]
Phenoxybenzamine DM8KSQH Malignant essential hypertension BA00 Approved [1]
Pramipexole DMNMW9R Parkinson disease 8A00.0 Approved [21]
Prazosin DMCD9YG Benign prostatic hyperplasia GA90 Approved [1]
Procainamide DMNMXR8 Ventricular arrhythmias BC71 Approved [4]
Procaterol DM1M0Q4 Asthma CA23 Approved [4]
Propranolol DM79NTF Angina pectoris BA40 Approved [9]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [22]
Ranitidine DM0GUSX Gastric ulcer DA60 Approved [23]
Rizatriptan DMDJMA3 Migraine 8A80 Approved [18]
Salbutamol DMN9CWF Acute asthma CA23 Approved [4]
Sitagliptin DMGDKXN Cystic fibrosis CA25 Approved [24]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [25]
Sumatriptan DMVYXR8 Cluster headache 8A81.0 Approved [4]
Terbutaline DMD4381 Asthma CA23 Approved [4]
Tiotropium DMFDC0Q Chronic obstructive pulmonary disease CA22 Approved [4]
Triamterene DM2HU9I Congestive heart failure BD10 Approved [4]
Trimethoprim DMM7CHK Acute otitis media AB00 Approved [4]
Trospium chloride DM32XZT Discovery agent N.A. Approved [26]
Tubocurarine DMBZIVP Anaesthesia 9A78.6 Approved [6]
Varenicline DMMUOLJ Drug dependence Approved [4]
Verapamil DMA7PEW Angina pectoris BA40 Approved [1]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [6]
Zolmitriptan DM1IB4Q Migraine 8A80 Approved [18]
Berberine DMC5Q8X N. A. N. A. Phase 4 [27]
------------------------------------------------------------------------------------
⏷ Show the Full List of 65 Approved Drug(s)
5 Clinical Trial Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Spermidine DMVJNFI Plaque psoriasis EA90.0 Phase 3 [6]
N1-methylnicotinamide DM16PWF Hyperlipidemia 5C80.Z Phase 2/3 [28]
Camostat DMQ7UL8 Cystic fibrosis CA25 Phase 2 [4]
YM155 DM5Q1W4 Breast cancer 2C60-2C65 Phase 2 [29]
PGF2alpha DM4XAU7 Solid tumour/cancer 2A00-2F9Z Clinical trial [30]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Phenformin DMQ52JG Diabetic complication 5A2Y Withdrawn from market [4]
------------------------------------------------------------------------------------
3 Preclinical Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
(R)-Xamoterol DMXWD08 N. A. N. A. Preclinical [4]
(S)-Xamoterol DM1ZQ5G N. A. N. A. Preclinical [4]
N-methylpyridinium DMVUKEW N. A. N. A. Preclinical [31]
------------------------------------------------------------------------------------
6 Investigative Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
benzamil DM57SVW Discovery agent N.A. Investigative [4]
CHOLINE DM5D9YK Insomnia 7A00-7A0Z Investigative [6]
PHENCYCLIDINE DMQBEYX Discovery agent N.A. Investigative [32]
Tetramethylammonium Ion DMLEPYN Discovery agent N.A. Investigative [33]
tyramine DM4UXT1 Discovery agent N.A. Investigative [6]
[14C]TEA DM6SFYH Discovery agent N.A. Investigative [34]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Investigative Drug(s)

References

1 Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 2006 Mar 8;234(1):4-33.
2 Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse. Respir Res. 2006 Apr 12;7:65.
3 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
4 Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42.
5 Selection and characterization of a human ovarian cancer cell line resistant to auranofin. Oncotarget. 2017 Oct 9;8(56):96062-96078.
6 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
7 Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006 Nov;319(2):879-86.
8 Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metab Pharmacokinet. 2008;23(4):243-53.
9 Influx Transport of Cationic Drug at the Blood-Retinal Barrier: Impact on the Retinal Delivery of Neuroprotectants. Biol Pharm Bull. 2017;40(8):1139-1145.
10 Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. Diabetes. 2015 May;64(5):1786-93.
11 The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1. Biochem Pharmacol. 2012 May 15;83(10):1427-34.
12 Are organic cation transporters capable of transporting prostaglandins? Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):125-30.
13 Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther. 2007 Mar;81(3):362-70.
14 Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia. Leuk Lymphoma. 2008 Apr;49(4):639-42.
15 Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection. Drug Metab Dispos. 2008 Aug;36(8):1616-23.
16 Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochem Pharmacol. 2012 Mar 15;83(6):805-14.
17 Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet. 2005 Oct;20(5):379-86.
18 OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics. Clin Pharmacol Ther. 2016 Jun;99(6):633-41.
19 Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res. 2006 Sep 1;66(17):8847-57.
20 Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters. Drug Metab Dispos. 2009 Feb;37(2):424-30.
21 OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Neurogenetics. 2011 Feb;12(1):79-82.
22 Comparison of type I and type II organic cation transport by organic cation transporters and organic anion-transporting polypeptides. J Pharmacol Exp Ther. 2001 Jul;298(1):110-5.
23 Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3). J Pharmacol Exp Ther. 2005 Dec;315(3):1288-97.
24 265 effect of dietary cholesterol on gallbladder bile lithogenicity and gene expression in the enterohepatic axis of non-obese gallstone and control women. Journal of Hepatology, 2009, 50(09):S105-S106.
25 Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma
26 Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics. Mol Pharm. 2015 Jan 5;12(1):171-8.
27 Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):449-61.
28 Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 1997 Jul;16(7):871-81.
29 Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant. Drug Metab Dispos. 2010 Jan;38(1):1-4.
30 Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther. 2002 Apr;301(1):293-8.
31 Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1. Diabetes. 2008 Jun;57(6):1463-9.
32 Drug transporters of platinum-based anticancer agents and their clinical significance. Drug Resist Updat. 2011 Feb;14(1):22-34.
33 Scintillation proximity assay for measuring uptake by the human drug transporters hOCT1, hOAT3, and hOATP1B1. Anal Biochem. 2007 Jul 15;366(2):117-25.
34 Involvement of human organic cation transporter 1 in the hepatic uptake of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel, small molecule survivin suppressant. Drug Metab Dispos. 2009 Sep;37(9):1856-63.